Bonus

Quote
















































anonymous said:
Only for Stage 3 is it good news.
Click to expand...

Wrong.

RAYALDEE is indicated for the treatment of secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease.

KDIGO 4.2.2: In adult patients with CKD G3a–G5 not on dialysis, we suggest that calcitriol and vitamin D analogs not be routinely used (2C). It is reasonable to reserve the use of calcitriol and vitamin D analogs for patients with CKD G4–G5 with severe and progressive hyperparathyroidism (Not Graded).

RAYALDEE is not indicated in patients with stage 5 chronic kidney disease or end-stage renal disease on dialysis. Currently, OPKO and Vifor Fresenius Medical Care Renal Pharma are currently jointly developing RAYALDEE® for dialysis patients.

Below shows the five stages of CKD and GFR for each stage:

Stage 1 with normal or high GFR (GFR > 90 mL/min)
Stage 2 Mild CKD (GFR = 60-89 mL/min)
Stage 3A Moderate CKD (GFR = 45-59 mL/min)
Stage 3B Moderate CKD (GFR = 30-44 mL/min)
Stage 4 Severe CKD (GFR = 15-29 mL/min)
Stage 5 End Stage CKD (GFR <15 mL/min)

KDIGO 4.2.4. In patients with CKD G5D and elevated or rising PTH, we suggest calcitriol, or vitamin D analogs, or calcimimetics, or a combination of calcimimetics and calcitriol or vitamin D analogs be used to lower PTH (2B).

This is good news for Rayaldee and it's intended indications on stage 3 or 4 chronic kidney disease, nuff said.
 


















anonymous said:
Two weeks left in the quarter and we still don't know how the RSS are getting paid. WTF.

The Top Rep only has 67 prescriptions for this quarter. Do you really think this person is going to gain another 40 prescriptions to make a total of 104 to achieve the total payout? Doubtful.
What's the big deal about paying everyone culmulatively? There is plenty of money left over from Q1 since no one got paid squat in Q1 plus the people they fired didn't get paid and the 2 reps that quit won't get paid for Q2. The money is there. STOP screwing the reps and we will be motivated to produce more prescriptions.
Click to expand...


Q2 Comp plan still unknown. WTF?? Only 4 days left. With only 6 SRFs going into OC, downwards we continue to spin.
 


















anonymous said:
Q2 Comp plan still unknown. WTF?? Only 4 days left. With only 6 SRFs going into OC, downwards we continue to spin.
Click to expand...

Don't be surprise to find out that they are going to wait until the end of June data is available to decide on the comp plan's grading curve. The company hasn't done right by the reps as of yet so don't expect anything better out of them regarding the comp plan. Remember, they FIRED people that had only been here 4 months for lack of performance plus the fired reps didn't receive severance or a bonus check. They also FIRED the inside sales force without any notice. They have't replaced all the people that have left. The "left over" money from Q1 hasn't been rolled into Q2. There was a ton of money left over and it went back into Frost's pocket.

So much for an uncapped bonus plan. Freaking joke!
 




































Top Bottom
Back
Quote